Basilea Pharmaceutica AG
BPMUF
$71.00
-$0.60-0.84%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 48.94M | 66.01M | 83.61M | 85.49M | 88.56M |
| Total Depreciation and Amortization | 4.57M | 4.38M | 4.23M | 4.10M | 4.04M |
| Total Amortization of Deferred Charges | 694.40K | 692.00K | 690.90K | 668.30K | 677.90K |
| Total Other Non-Cash Items | 10.41M | 7.02M | 3.61M | -5.98M | -15.44M |
| Change in Net Operating Assets | 11.02M | 5.22M | -570.30K | 3.21M | 7.08M |
| Cash from Operations | 75.63M | 83.33M | 91.56M | 87.50M | 84.92M |
| Capital Expenditure | -3.25M | -2.52M | -1.80M | -1.86M | -1.95M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | 0.00 | 0.00 | 431.80K | 878.40K |
| Other Investing Activities | -294.50K | -217.70K | -141.40K | -114.30K | -92.90K |
| Cash from Investing | -3.54M | -2.74M | -1.94M | -1.55M | -1.17M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | 0.00 | -7.80M | -15.60M |
| Issuance of Common Stock | 692.00K | 673.00K | 654.00K | 1.56M | 2.46M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -22.12M | -18.63M | -15.15M | -7.58M | -21.00K |
| Cash from Financing | -25.52M | -21.18M | -16.84M | -15.34M | -14.81M |
| Foreign Exchange rate Adjustments | -31.60K | -55.80K | -80.50K | -13.50K | 54.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 46.53M | 59.36M | 72.70M | 70.60M | 69.00M |